Cite Filings / INDP / 9999999995-22-002655

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Indaptus Therapeutics, Inc. Filed 2022-09-09 Acc 9999999995-22-002655

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2022-12-30 EFFECT Notice of Effectiveness
2022-09-09 EFFECT Notice of Effectiveness
2022-09-09 RW RW
2022-09-09 4 Chief Business Officer bought 150 shares at $2.62 ($393)
2022-09-08 4 CEO and Director bought 9,692 shares at an average $2.56 ($24,771)
2022-09-07 CORRESP Correspondence Between Filers and SEC Staff
2022-03-23 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…